September 19, 2017 IMPLANET (Paris:IMPL) (OTCQX:IMPZY) (Euronext Growth: ALIMP, FR0010458729, PEA-PME eligible), a medical technology company specializing in vertebral and knee-surgery implants, announces its results for the first half of the current year to June 30, 2017, as approved by the Board at its meeting of September 19, 2017. In […]